Skip to main content
Log in

Milk fortified with vitamin D could reduce the prevalence of vitamin D deficiency among Japanese female college students

  • Original Article
  • Published:
Archives of Osteoporosis Aims and scope Submit manuscript

An Erratum to this article was published on 23 June 2015

Abstract

Summary

The mean serum 25-OH-D was 23.1 ng/mL in 49 female Japanese college students, and concentrations in 33 % of them were ≤20 ng/mL. Subsequently, they consumed milk fortified with 2 μg of vitamin D daily for 8 weeks. Then, 25-OH-D increased to 36.0 ng/mL and all values were ≥20 ng/mL.

Purpose

Commercial milk in the USA is fortified with vitamin D (VD), whereas food fortified with VD is unpopular in Japan even though dietary sources of this vitamin are limited. Therefore, young Japanese females might be VD deficient. This study assesses the effects of ingesting milk fortified with VD among Japanese female college students.

Methods

Forty-nine female college students consumed 180 mL of milk fortified with 2 μg of VD daily for 8 weeks. This amount of VD in the milk was similar to that in commercial milk sold in the USA. Serum concentrations of 25-OH-D were measured in venous blood collected before and after the ingestion period.

Results

The initial serum 25-OH-D concentration was 23.1 ng/mL and concentrations in 33 % of the participants were ≤20 ng/mL. After 8 weeks, serum 25-OH-D increased to 36.0 ng/mL and all values were ≥20 ng/mL. Serum Ca and FGF-23 also increased and PTH, NTX, and BAP significantly decreased.

Conclusions

The high prevalence of VD deficiency in Japanese female college students was decreased by consuming VD-fortified milk.

This is a preview of subscription content, log in via an institution to check access.

Access this article

Price excludes VAT (USA)
Tax calculation will be finalised during checkout.

Instant access to the full article PDF.

Fig. 1
Fig. 2
Fig. 3
Fig. 4

Similar content being viewed by others

References

  1. Bentley J (2013) Vitamin D deficiency: identifying gaps in the evidence base. Nurs Stand 27:35–41. doi:10.7748/ns2013.07.27.46.35.e7388

    Article  PubMed  Google Scholar 

  2. Nakamura K, Nashimoto M, Tsuchiya Y, Obata A, Miyanishi K, Yamamoto M (2001) Vitamin D insufficiency in Japanese female college students: a preliminary report. Int J Vitam Nutr Res 71:302–305

    Article  CAS  PubMed  Google Scholar 

  3. Nakamura K, Nashimoto M, Matsuyama S, Yamamoto M (2001) Low serum concentrations of 25-hydroxyvitamin D in young adult Japanese women: a cross sectional study. Nutrition 17:921–925

    Article  CAS  PubMed  Google Scholar 

  4. Tsugawa N, Okano T (2009) Vitamin D and osteoporosis. Vitamins 83:651–658 (in Japanese)

    CAS  Google Scholar 

  5. Institute of Medicine (US) Committee to Review Dietary Reference Intakes for Vitamin D and Calcium, Ross AC, Taylor CL, Yaktine AL, Del Valle HB (eds) (2011) Dietary reference intakes for calcium and Vitamin D. National Academies Press (US), Washington DC

    Google Scholar 

  6. Tanaka K, Terao J, Shidoji Y, Tamai H, Imai E, Okano T (2013) Dietary reference intakes for Japanese 2010: fat-soluble vitamins. J Nutr Sci Vitaminol 59:S57–S66

    Article  CAS  Google Scholar 

  7. Japanese Ministry of Agriculture, Forestry and Fisheries (2012) Fisheries of Japan-FY2011 (2011/2012) Fisheries policy outline for FY2012 (White Paper on Fisheries: Summary) p.12, http://www.maff.go.jp/e/

  8. Patterson KY, Phillips KM, Horst RL, Byrdwell WC, Exler J, Lemar LE, Holden JM (2010) Vitamin D content and variability in fluid milks from a US Department of Agriculture nationwide sampling to update values in the National Nutrient Database for Standard Reference. J Dairy Sci 93:5082–5090

    Article  CAS  PubMed  Google Scholar 

  9. Kobayashi S, Honda S, Murakami K, Sasaki S, Okubo H, Hirota N, Notsu A, Fukui M, Date C (2011) Both comprehensive and brief-type self-administered diet history questionnaires have reasonable ranking ability for nutrient intakes compared with 16-day dietary records in Japanese adults. J Epidemiol 22:151–159

    Article  Google Scholar 

  10. Sasaki S, Katagiri A, Tsuji T, Shimoda T, Amano K (2003) Self-reported rate of eating correlates with body mass index in 18-y-old Japanese women. Int J Obes Relat Metab Disord 27:1405–1410

    Article  CAS  PubMed  Google Scholar 

  11. Natoinal Institute of Health and Nutrition (2007) Outline of the National Health and Nutrition Survey Japan. http://www0.nih.go.jp/eiken/english/research/pdf/nhns2007.pdf

  12. Ohta H, Kuroda T, Onoe Y, Orito S, Ohara M, Kume M, Harada A, Tsugawa N, Okano T, Sasaki S (2009) The impact of lifestyle factors on serum 25-hydroxyvitamin D levels: a cross-sectional study in Japanese women aged 19–25 years. J Bone Miner Metab 27:682–688. doi:10.1007/s00774-009-0095-1

    Article  CAS  PubMed  Google Scholar 

  13. Ono Y, Suzuki A, Kotake M, Zhang X, Nishiwaki-Yasuda K, Ishiwata Y, Imamura S, Nagata M, Takamoto S, Itoh M (2005) Seasonal changes of serum 25-hydroxyvitamin D and intact parathyroid hormone levels in a normal Japanese population. J Bone Miner Metab 23:147–151

    Article  CAS  PubMed  Google Scholar 

  14. Woo J, Lau W, Xu L, Lam CW, Zhao X, Yu W, Xing X, Lau E, Kuhn-Sherlock B, Pocock N, Eastell R (2007) Milk supplementation and bone health in young adult Chinese women. J Womens Health (Larchmt) 16:692–702

    Article  Google Scholar 

  15. Harris RA, Pedersen-White J, Guo DH, Stallmann-Jorgensen IS, Keeton D, Huang Y, Shah Y, Zhu H, Dong Y (2011) Vitamin D3 supplementation for 16 weeks improves flow-mediated dilation in overweight African-American adults. Am J Hypertens 24:557–562. doi:10.1038/ajh.2011.12

    Article  CAS  PubMed  Google Scholar 

  16. Riggs BL, O’Fallon WM, Muhs J, O’Connor MK, Kumar R, Melton LJ 3rd (1998) Long-term effects of calcium supplementation on serum parathyroid hormone level, bone turnover, and bone loss in elderly women. J Bone Miner Res 13:168–174

    Article  CAS  PubMed  Google Scholar 

  17. Uchida S, Taniguchi T, Shimizu T, Kakikawa T, Okuyama K, Okaniwa M, Arizono H, Nagata K, Santora AC, Shiraki M, Fukunaga M, Tomomitsu T, Ohashi Y, Nakamura T (2005) Therapeutic effects of alendronate 35 mg once weekly and 5 mg once daily in Japanese patients with osteoporosis: a double-blind, randomized study. J Bone Miner Metab 23:382–388

    Article  CAS  PubMed  Google Scholar 

  18. Shiraki M, Nakamura T, Fukunaga M, Sone T, Usami A, Inoue T (2012) A multicenter randomized double-masked comparative study of different preparations of alendronate in osteoporosis—monthly (four weeks) intravenous versus once weekly oral administrations. Curr Med Res Opin 28:1357–1367. doi:10.1185/03007995.2012.709838

    Article  CAS  PubMed  Google Scholar 

  19. Fukunaga M, Kushida K, Kishimoto H, Shiraki M, Taketani Y, Minaguchi H, Inoue T, Morita R, Morii H, Yamamoto K, Ohashi Y, Orimo H (2002) Risedronate Phase III Research Group. A comparison of the effect of risedronate and etidronate on lumbar bone mineral density in Japanese patients with osteoporosis: a randomized controlled trial. Osteoporos Int 13:971–979

    Article  CAS  PubMed  Google Scholar 

  20. Kishimoto H, Fukunaga M, Kushida K, Shiraki M, Itabashi A, Nawata H, Nakamura T, Ohta H, Takaoka K, Ohashi Y (2006) Risedronate Phase III Research Group. Efficacy and tolerability of once-weekly administration of 17.5 mg risedronate in Japanese patients with involutional osteoporosis: a comparison with 2.5-mg once-daily dosage regimen. J Bone Miner Metab 24:405–413

    Article  CAS  PubMed  Google Scholar 

  21. Okazaki R, Hagino H, Ito M, Sone T, Nakamura T, Mizunuma H, Fukunaga M, Shiraki M, Nishizawa Y, Ohashi Y, Matsumoto T (2012) Efficacy and safety of monthly oral minodronate in patients with involutional osteoporosis. Osteoporos Int 23:1737–1745. doi:10.1007/s00198-011-1782-z

    Article  CAS  PubMed Central  PubMed  Google Scholar 

  22. Morii H, Ohashi Y, Taketani Y, Fukunaga M, Nakamura T, Itabashi A, Sarkar S, Harper K (2003) Effect of raloxifene on bone mineral density and biochemical markers of bone turnover in Japanese postmenopausal women with osteoporosis: results from a randomized placebo-controlled trial. Osteoporos Int 14:793–800

    Article  CAS  PubMed  Google Scholar 

  23. Itabashi A, Yoh K, Chines AA, Miki T, Takada M, Sato H, Gorai I, Sugimoto T, Mizunuma H, Ochi H, Constantine GD, Ohta H (2011) Effects of bazedoxifene on bone mineral density, bone turnover, and safety in postmenopausal Japanese women with osteoporosis. J Bone Miner Res 26:519–529. doi:10.1002/jbmr.252

    Article  CAS  PubMed  Google Scholar 

  24. Nakamura T, Matsumoto T, Sugimoto T, Shiraki M (2012) Dose–response study of denosumab on bone mineral density and bone turnover markers in Japanese postmenopausal women with osteoporosis. Osteoporos Int 23:1131–1140. doi:10.1007/s00198-011-1786-8

    Article  CAS  PubMed  Google Scholar 

  25. Miyauchi A, Matsumoto T, Sugimoto T, Tsujimoto M, Warner MR, Nakamura T (2010) Effects of teriparatide on bone mineral density and bone turnover markers in Japanese subjects with osteoporosis at high risk of fracture in a 24-month clinical study: 12-month, randomized, placebo-controlled, double-blind and 12-month open-label phases. Bone 47:493–502. doi:10.1016/j.bone.2010.05.022

    Article  CAS  PubMed  Google Scholar 

  26. Wesseling-Perry K, Pereira RC, Sahney S, Gales B, Wang HJ, Elashoff R, Jüppner H, Salusky IB (2011) Calcitriol and doxercalciferol are equivalent in controlling bone turnover, suppressing parathyroid hormone, and increasing fibroblast growth factor-23 in secondary hyperparathyroidism. Kidney Int 79:112–119. doi:10.1038/ki.2010.352

    Article  CAS  PubMed  Google Scholar 

  27. Arya V, Bhambri R, Godbole MM, Mithal A (2004) Vitamin D status and its relationship with bone mineral density in healthy Asian Indians. Osteoporos Int 15:56–61

    Article  CAS  PubMed  Google Scholar 

  28. Fraser WD, Milan AM (2013) Vitamin D assays: past and present debates, difficulties, and developments. Calcif Tissue Int 92:118–127. doi:10.1007/s00223-012-9693-3.29

    Article  CAS  PubMed  Google Scholar 

  29. Liu S, Tang W, Zhou J, Stubbs JR, Luo Q, Pi M, Quarles LD (2006) Fibroblast growth factor 23 is a counter-regulatory phosphaturic hormone for vitamin D. J Am Soc Nephrol 17:1305–1315

    Article  CAS  PubMed  Google Scholar 

Download references

Acknowledgments

This study was funded partly by the Japan Dairy Association (J-milk). The fortified milk used in this study was a gift from Meiji Co. Ltd. (Tokyo, Japan). Part of this study was presented at a local meeting of the Japanese Society of Physical Fitness and Sports Medicine during March 2014 in Tokyo, Japan.

Conflicts of interest

None.

Author information

Authors and Affiliations

Authors

Corresponding author

Correspondence to Yoshio Suzuki.

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Suzuki, Y., Maruyama-Nagao, A., Sakuraba, K. et al. Milk fortified with vitamin D could reduce the prevalence of vitamin D deficiency among Japanese female college students. Arch Osteoporos 9, 188 (2014). https://doi.org/10.1007/s11657-014-0188-x

Download citation

  • Received:

  • Accepted:

  • Published:

  • DOI: https://doi.org/10.1007/s11657-014-0188-x

Keywords

Navigation